使Cemiplimab

Scott Strum1,2, Seth Climans1,2, Victoria Purcell3

  • 1Department of Oncology, Division of Medical Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

概括

塞米普利马布在加拿大现实环境中对晚期皮肤状细胞癌 (cSCC) 显示了可容忍的毒性和有效性. 这项研究提供了关于耐火局部晚期和转移性cSCC患者治疗结果的关键数据.